Journal
/
Immunology and Infection
/
Screening of β2 Integrin Activation Inhibitors in Human Neutrophils
/
Author Spotlight: Development of a Method for Identifying Small Molecular Antagonists of β2 Integrin Activation
JoVE Journal
Immunology and Infection
A subscription to JoVE is required to view this content.  Sign in or start your free trial.
JoVE Journal Immunology and Infection
A Flow Cytometry-Based High-Throughput Technique for Screening Integrin-Inhibitory Drugs

Author Spotlight: Development of a Method for Identifying Small Molecular Antagonists of β2 Integrin Activation

Screening of β2 Integrin Activation Inhibitors in Human Neutrophils

DOI:
10.3791/64401-v

•

00:45 min

•

February 02, 2024

•

, , , ,
1Department of Immunology, School of Medicine,UConn Health, 2Center for Molecular Discovery,University of New Mexico Health Sciences Center, 3Comprehensive Cancer Center,University of New Mexico Health Sciences Center, 4Department of Pathology,University of New Mexico Health Sciences Center, 5Autophagy, Inflammation, & Metabolism (AIM) Center,University of New Mexico

Tags

Flow CytometryHigh-throughput ScreeningIntegrin InhibitorBeta-2 IntegrinNeutrophilAnti-inflammatoryConformational Change AntibodyFMLPGPCR

Embed

ADD TO PLAYLIST

Usage Statistics

Related Videos

Author Spotlight: Development of a Method for Identifying Small Molecular Antagonists of β2 Integrin Activation

High-Throughput Screening of Compounds Using Neutrophils Isolated from Human Blood in a 384-Well Plate Format

Neutrophils Screening Assay Using Flow Cytometry

Read Article